The Effect of Combined Bilateral Infraorbital and Infratrochlear Nerve Block in Nasal Surgeries

NCT ID: NCT06174675

Last Updated: 2024-12-04

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 40 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-01-01
• Study Completion Date: 2024-09-01

Brief Summary

The aim of the study is to assess the efficacy of adding a pre-emptive combined bilateral infraorbital and infratrochlear nerve blocks with bupivacaine 0.25% in decreasing intraoperative and postoperative analgesics consumption and maintaining intraoperative hemodynamic stability during nasal surgeries.

Detailed Description

Perioperative pain management is one of the most important issues of most surgical procedures. The goal of every pain management technique is to reduce or eliminate pain and discomfort with minimum side effects (Garmella and Cellini, 2012).

Nasal surgical procedures are associated with a high incidence of emergence agitation leading to severe complications such as bleeding and delayed recovery which increase the hospital stay (Kim et al., 2015).

Although the cause of emergence agitation is not well established, Pain in the immediate post-operative period is one of the significant risk factors for emergence agitation. Multiple analgesic interventions are applied to the patient before, during and after surgery prevent these complications (Gray et al., 2018).

The most utilized analgesic interventions are combinations of narcotic and non-steroidal anti-inflammatory drugs. However, they are associated with gastrointestinal and neurological side effects which cause discomfort to the patient and affect surgical recovery profile (Çelik et al., 2018). Therefore, the utility of combining regional nerve block with general anesthesia has been popularized in clinical practice to provide improved perioperative analgesia, decreased narcotic consumption and enhanced emergence and recovery characteristics (Mariano et al., 2009; Ibrahim et al., 2018).

The infraorbital nerve (ION) is a branch of the maxillary part of the trigeminal nerve. This nerve innervates the skin of the nose and septum mobile nasi. The infratrochlear nerve (ITN) innervates the root of the nose and is an extraconal branch of the nasociliary nerve, which is a branch of the ophthalmic portion of the trigeminal nerve (Choi et al., 2019).

Although these nerve blocks are simple and easy to use with few complications, there are limited reports that suggest combined bilateral infraorbital and infratrochlear nerve blocks to be effective to facilitate pain management and reduce anesthetic agent consumption and perioperative dose of narcotics in nasal procedures (Cekic et al., 2013; Boselli et al., 2016).

Conditions

Anesthesia

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: DOUBLE

Study Groups

Study group

patients will receive combined bilateral infraorbital and infratrochlear nerve block.

20 patients

Group Type: ACTIVE_COMPARATOR

combined bilateral infraorbital and infratrochlear nerve blocks

Intervention Type: PROCEDURE

Filling the block labelled syringe with 8 mL of bupivacaine 0.25%. Starting with Infraorbital nerve block using an extraoral approach.Inserting a 25-gauge needle laterally to the ipsilateral nostril after palpating the infraorbital ridge to locate the infraorbital foramen. Positioning of the index finger of the non-dominant hand above the infraorbital foramen and advancing the needle feeling it beneath the finger to avoid globe penetration injury. Injecting 3 mL of the study solution slowly after confirming negative aspiration of blood and taking care not to inject into the foramen itself.

Shifting to infratrochlear nerve block by inserting the needle 1 cm above the inner canthus targeting the junction of the orbit and the nasal bone. Injecting 1mL of the study solution after confirming negative aspiration of blood.

Performing contralateral nerve block in the same manner. Applying pressure to four injection points for one minute to prevent hematoma.

control group

patients will not receive the block and will receive intravenous analgesia according to standard protocol.

20 patients.

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

combined bilateral infraorbital and infratrochlear nerve blocks

Filling the block labelled syringe with 8 mL of bupivacaine 0.25%. Starting with Infraorbital nerve block using an extraoral approach.Inserting a 25-gauge needle laterally to the ipsilateral nostril after palpating the infraorbital ridge to locate the infraorbital foramen. Positioning of the index finger of the non-dominant hand above the infraorbital foramen and advancing the needle feeling it beneath the finger to avoid globe penetration injury. Injecting 3 mL of the study solution slowly after confirming negative aspiration of blood and taking care not to inject into the foramen itself.

Shifting to infratrochlear nerve block by inserting the needle 1 cm above the inner canthus targeting the junction of the orbit and the nasal bone. Injecting 1mL of the study solution after confirming negative aspiration of blood.

Performing contralateral nerve block in the same manner. Applying pressure to four injection points for one minute to prevent hematoma.

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

1. Age group: 18 - 55 years old.

2. American Society of Anesthesiologists (ASA) Physical Status Class I or II

3. Scheduled for elective nasal surgery under general anesthesia.

Exclusion Criteria

1. Refusing to participate in the study or inability to provide informed consent.

2. History of allergy to the medications used in the study.

3. Contraindications to regional anesthesia (including coagulopathy, INR ≥ 1.4 and local infection).

4. Compromised renal or liver functions.

5. History of substance or alcohol abuse.

6. Pre-existing chronic pain of different etiology.

7. Psychiatric disorders.

8. Pregnancy.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 55 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Ain Shams University

OTHER

Sponsor Role: lead

Responsible Party

Ayat Mohamed Elshaer

assistant lecturer of anesthesia

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Ayat Elshaer, ass.lecturer

Role: PRINCIPAL_INVESTIGATOR

faculty of medicine, Ain Shams University

Locations

Ain shams university hospitals

Cairo, Cairo Governorate, Egypt

Countries

Egypt

Other Identifiers

FMASU MD136/2023

Identifier Type: -

Identifier Source: org_study_id